Category Archives: Co-infections

Association between the CD209 promoter -336A/G polymorphism and susceptibility to tuberculosis: A meta-analysis

2012

Background and objective: Dendritic cell-specific intracellular adhesion molecule-3 grabbing nonintegrin (DC-SIGN), encoded by the CD209 gene, is a major Mycobacterium tuberculosis receptor on human dendritic cells. The potentially functional -336A/G...

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: A meta-analysis

2005

Background. A major difficulty associated with the use of standard therapy with isoniazid for latent tuberculosis infection is poor patient adherence to therapy because of the prolonged course required. Shorter...

Assessing tuberculosis case fatality ratio: A meta-analysis

2011

BACKGROUND: Recently, the tuberculosis (TB) Task Force Impact Measurement acknowledged the need to review the assumptions underlying the TB mortality estimates published annually by the World Health Organization (WHO). TB...

Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection

2011

BACKGROUND: It is unclear whether human immunodeficiency virus (HIV) increases the risk of tuberculosis (TB) mainly through reactivation or following recent Mycobacterium tuberculosis (re)infection. Within a DNA fingerprint-defined cluster of...

Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: A systematic review

2010

HIV and tuberculosis (TB) are leading global causes of mortality and morbidity. Highly active antiretroviral therapy (HAART) is often initiated in patients being treated for TB. The immune recovery associated...

Predictive value of interferon- release assays for incident active tuberculosis: A systematic review and meta-analysis

2012

Background: We aimed to assess whether interferon- release assays (IGRAs) can predict the development of active tuberculosis and whether the predictive ability of these tests is better than that of...

Treatment of cryptosporidiosis in immunocompromised individuals: Systematic review and meta-analysis

2007

Cryptosporidium is a common cause of gastroenteritis and is associated with severe life-threatening illness among immunocompromised individuals. This review aimed to assess the efficacy of interventions for the treatment and...

Cotrimoxazole prophylaxis for opportunistic infections in adults with HIV

2003

BACKGROUND: The prevention and early treatment of infections are the mainstay of the medical management of the majority of people with HIV infection, who live in low income countries without...

HIV prevention programs with heterosexuals

2000

Objective: Efficacious HIV prevention programs designed for heterosexual adults were identified. Methods: Thirty-two programs designed with a comparison group and aimed at preventing heterosexual transmission for HIV were identified utilizing...

A meta-analysis of the efficacy of HIV/AIDS prevention interventions in Asia, 1995-2009

2012

The HIV/AIDS epidemic continues to grow in pockets across Asia, despite early successes at curtailing its spread in countries like Thailand. Recent evidence documents dramatic increases in incidence among risk...

Meta-analysis of prevention and treatment of toxoplasmic encephalitis in HIV-infected patients

2013

Toxoplasmic encephalitis (TE) is one of the most common central nervous system (CNS) opportunistic infections in HIV-infected patients. It can be prevented and treated through drug regimen. However, drugs have...

Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis by Etiology

2012

Many national guidelines recommend annual influenza vaccination of immunocompromised patients, although the decision to vaccinate is usually at clinical discretion. We conducted a systematic review and meta-analyses to assess the...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!